← Open Payments lookup

SARA SOSA: Open Payments

NPI 1356794846 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,611 in 142 payments from 15 companies in 2025. Trend: 2023 $1,159 · 2024 $1,696 · 2025 $2,611

Food & beverage: $2,611
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)41$671
Teva Pharmaceuticals USA, Inc.23$532
Alkermes, Inc.17$296
Otsuka America Pharmaceutical, Inc.10$191
Lundbeck LLC11$187
ABBVIE INC.10$143
Neurocrine BioSciences, Inc.8$132
Supernus Pharmaceuticals, Inc.3$97
E.R. Squibb & Sons, L.L.C.5$85
Takeda Pharmaceuticals U.S.A., Inc.4$64

Products named: CAPLYTA, REXULTI, UZEDY, ARISTADA, AUSTEDO XR, VRAYLAR, INGREZZA, Qelbree.

Industry payments across TX — which companies pay providers there.